Salomon & Ludwin’s Gilead Sciences GILD Stock Holding History

Salomon & Ludwin’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$92.2K	Hold	660	–	–	0.01%	268
2025 Q4	$78.1K	Buy	660 +178	+37%	+$21.6K	0.01%	287
2025 Q3	$54.3K	Buy	482 +282	+141%	+$32.1K	﹤0.01%	364
2025 Q2	$22.3K	Buy	+200	New	+$21.3K	﹤0.01%	371
2024 Q4	–	Sell	-18	Closed	-$1.51K	–	732
2024 Q3	$1.51K	Hold	18	–	–	﹤0.01%	634
2024 Q2	$1.24K	Sell	18 -1,375	-99%	-$91.8K	﹤0.01%	646
2024 Q1	$100K	Sell	1,393 -100	-7%	-$7.69K	0.01%	256
2023 Q4	$112K	Hold	1,493	–	–	0.01%	212
2023 Q3	$112K	Buy	+1,493	New	+$115K	0.01%	212
2019 Q2	–	Sell	-18	Closed	-$1K	–	235
2019 Q1	$1K	Buy	+18	New	+$1.2K	﹤0.01%	237

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Salomon & Ludwin's GILD Position: Q1 2026 in Review

Salomon & Ludwin held its Gilead Sciences (GILD) position steady in Q1 2026 at 660 shares worth $92.2K. The position accounts for 0.01% of the portfolio, ranked #268.

Salomon & Ludwin first reported a position in GILD in Q1 2019 and has held it in 10 quarters since. The position peaked at $112K in Q4 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Salomon & Ludwin held 660 shares of Gilead Sciences worth $92.2K as of Q1 2026.
Salomon & Ludwin left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #268 holding.
Salomon & Ludwin first reported a position in Gilead Sciences in Q1 2019 and has held it in 10 quarters since.
Salomon & Ludwin's Gilead Sciences position peaked at $112K in Q4 2023.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.